e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Pneumonia and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Factors affecting treatment success in community acquired pneumonia (CAP)
C. Gündüz, M. S. Tasbakan, A. Sayiner, A. çilli, B. Karaboga, O. Kilinç, O. Kiliç, A. Sakar Coskun, C. çetinkaya, A. Hazar, F. Tokgöz (Izmir, Antalya, Manisa, Istanbul, Turkey)
Source:
Annual Congress 2013 –Pneumonia and sepsis
Session:
Pneumonia and sepsis
Session type:
Poster Discussion
Number:
299
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Gündüz, M. S. Tasbakan, A. Sayiner, A. çilli, B. Karaboga, O. Kilinç, O. Kiliç, A. Sakar Coskun, C. çetinkaya, A. Hazar, F. Tokgöz (Izmir, Antalya, Manisa, Istanbul, Turkey). Factors affecting treatment success in community acquired pneumonia (CAP). Eur Respir J 2013; 42: Suppl. 57, 299
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The impact of mixed etiology in community acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Factors affecting short and long-term mortality after community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Risk factors for pleural complications in children with community acquired pneumonia
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Could the initial use of antipseudomonal agents improve the prognosis for non-hospital acquired pneumonia?
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Predictors of length of stay in hospitalized patients with community acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Early discharge of community acquired pneumonia (CAP) patients with community respiratory assessment services (RAS) follow up in a UK DGH
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Surfactant-enforced treatment of
pseudomonas
-induced pneumonia
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Severity scores and management of community acquired pneumonia
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Development of an antibody therapy for the treatment of pneumonia
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept